Trialzen
Trialzen is a Belgian SaaS company that develops the Forecast & Planning Solution (FPS), a cloud platform for clinical trial supply chain forecasting, scenario modeling and RTSM/IRT integration, sold via all-inclusive annual subscriptions to pharmaceutical sponsors and delivered through CRO/CMO partners and a Perceptive eClinical alliance.
- Company typePrivate
- Founded2021
- HeadquartersLasne-chapelle-saint-lambert, Belgium
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Trialzen does
Trialzen SA is a Belgian private SaaS company founded in 2021 by former n-Side executives Cédric Druck (CEO/CTO), Bruno Coppé (Chairman) and Yves Pochet (Scientific Adviser), headquartered in Lasne, Belgium. It develops the Trialzen Forecast & Planning Solution (FPS), a cloud-based software platform for clinical trial supply chain forecasting, scenario modeling and optimization aimed at pharmaceutical sponsors running global clinical trials, with particular emphasis on oncology and advanced therapy trials. The product combines mathematical optimization, stochastic (Monte Carlo) modeling, real-time RTSM/IRT integration, AI-powered automated release plan generation, and a standard API for enterprise dashboards. Its core value proposition addresses the well-documented industry problem that approximately 50% of manufactured clinical trial drug supply is never administered to patients, with the company citing documented client outcomes of 50x ROI, a 20% reduction in site shipments, and per-study savings exceeding $1 million.
Trialzen operates an enterprise sales-led go-to-market with an all-inclusive annual subscription pricing model (no per-feature fees), supplemented by demo and sandbox environments and active participation in industry events such as GCSG, CSForum, COGEurope and CSDG. Distribution is delivered through direct sales to pharmaceutical sponsors and a partner network of CROs, CMOs and supply chain consultants; in April 2026 Trialzen announced a strategic alliance with Perceptive eClinical to launch Perceptive Clinical Intelligence, embedding its forecasting and simulation engine into Perceptive's Clinphone Pro IRT platform. The company maintains ISO 27001-aligned security controls and GDPR compliance, and has shipped four major platform releases since its v1.0.0 launch in April 2024, most recently v1.8.0 in February 2026. No external venture funding rounds, institutional investors, or parent company ownership signals are disclosed in the available sources.
Trialzen firmographics
Firmographics- Name
- Trialzen
- Legal name
- Trialzen SA
- Website
- https://trialzen.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Trialzen is a Belgian SaaS company that develops the Forecast & Planning Solution (FPS), a cloud platform for clinical trial supply chain forecasting, scenario modeling and RTSM/IRT integration, sold via all-inclusive annual subscriptions to pharmaceutical sponsors and delivered through CRO/CMO partners and a Perceptive eClinical alliance.
- Ownership category
- akta.pro rank
Trialzen industry classification
Industry- Product category
- Clinical Trial Supply Chain Software
- NAICS
- Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH)
Keywords
Where Trialzen is headquartered
LocationHeadquarters
- HQ city
- Lasne-chapelle-saint-lambert
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Trialzen business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription - Forecast & Planning Solution (FPS): Software-as-a-service subscription model offering access to Trialzen's forecasting and planning capabilities. All-inclusive pricing model with no per-feature fees. Customers can access demos and sandbox environments before purchase.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | All-inclusive SaaS subscription |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Trialzen product offering
Product offeringCore offering
Trialzen develops and sells a SaaS platform, the Forecast & Planning Solution (FPS), that enables pharmaceutical sponsors to forecast, plan, and optimize the supply chain for clinical trials. The platform uses stochastic modeling and mathematical optimization to reduce clinical drug waste, optimize RTSM/IRT parameters, and run scenario simulations across complex protocol designs including adaptive trials and oncology studies. Customers access the platform via annual all-inclusive subscriptions and can also engage joint consultancy services through the Perceptive Clinical Intelligence alliance with Perceptive eClinical.
Product overview
Trialzen offers a unified product portfolio centered on its Forecast & Planning Solution (FPS), a SaaS platform for clinical trial supply chain management. The core FPS product provides end-to-end forecasting, planning, and optimization capabilities including real-time RTSM/IRT integration, scenario modeling, and automated release planning. Through the Perceptive Clinical Intelligence alliance, Trialzen's simulation engine is embedded within Perceptive eClinical's Clinphone Pro platform to deliver integrated consultancy services spanning the entire clinical trial lifecycle from early supply planning through mid-study forecast adjustments.
Differentiator
Problem solved
Functional benefit
Products and services
- Trialzen FPS (Forecast & Planning Solution) SaaS platform providing clinical trial supply chain forecasting, planning, and optimization for pharmaceutical sponsors. Enables design of forecasting models per protocol specifications, optimization of supply budgets, alignment of supply chain with trial schedules, and minimization of overage and waste through predictive analytics, scenario modeling, RTSM/IRT integration, and AI-powered automated release planning.
- Perceptive Clinical Intelligence Technology-enabled clinical supply consultancy service combining Perceptive eClinical's randomization and clinical supply expertise with Trialzen's forecasting and simulation engine, integrated into Perceptive's Clinphone Pro IRT platform. Lets sponsors execute integrated supply planning across the full clinical trial lifecycle, from early supply planning through mid-study forecast adjustments.
Quantifiable outcome
- 50x ROI (5,000%) for clients
- +3 more outcomes
Companies that use Trialzen
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Trialzen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature10 records
Trialzen partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Perceptive eClinicalcoreStrategic alliance to launch 'Perceptive Clinical Intelligence' - a technology-enabled clinical supply consultancy service. Combines Perceptive's 30 years of clinical supply expertise and Clinphone Pro IRT platform with Trialzen's advanced forecasting and simulation technologies. Enables sponsors to move from scenario planning to operational action in a single integrated environment. Engagements reportedly generate savings exceeding $1 million per study.
- COGEuropeminorContent partnership with COGEurope (The PBC Group). Trialzen serves as a content partner for the annual conference, with Cedric Druck presenting and company having visibility at the event.
- CROs, CMOs, and Supply Chain ConsultantscorePartner network of contract research organizations, contract manufacturing organizations, and supply chain management consultants who provide expert guidance to sponsors using Trialzen's software.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Trialzen competitors and assessment
Company assessmentBroad incumbents
- Clario: Clario (formed from the merger of Bioclinica and ERT) delivers clinical trial endpoint technology, imaging, and RTSM/supply chain solutions. It overlaps with Trialzen in clinical supply and trial technology for pharma sponsors and CROs.
- Oracle Clinical One: Oracle's Clinical One platform offers randomization, supply management, and trial operations as part of a broad life sciences cloud suite. As a large incumbent, it represents a competitive threat via bundling and an integration partner for Trialzen's complementary forecasting layer.
- Veeva Systems: Veeva Vault CTMS and Vault EDC are enterprise clinical trial platforms used by most large pharma sponsors. While not a pure-play in supply forecasting, Veeva's broad installed base and clinical operations suite make it a key incumbent that could bundle or compete with Trialzen's specialized supply planning.
- Medidata (Dassault Systèmes): Medidata, a Dassault Systèmes company, provides a comprehensive clinical trial platform including Rave RTSM and supply management modules. Its broad installed base at top pharma sponsors makes it a key incumbent player in the same customer conversation as Trialzen.
Direct peers
- Signant Health: Signant Health is a clinical trial technology provider offering RTSM/IRT, patient-centric tools, and clinical supply solutions. It directly overlaps with Trialzen's supply forecasting and RTSM integration value proposition and serves the same pharma sponsor customer base.
- n-Side: n-Side is the founders' former company and direct competitor in clinical supply forecasting and optimization, offering analogous services for clinical trial supply chains. Trialzen's founders (Cédric Druck, Bruno Coppè, Yves Pochet) built n-Side before starting Trialzen, making it the most directly comparable competitor.
- 4G Clinical: 4G Clinical provides randomization and trial supply management (RTSM/IRT) technology, including supply forecasting capabilities, for clinical trials. Trialzen's CEO Cédric Druck previously worked at 4G Clinical, and both companies compete for medical-supply and forecasting budgets at pharma sponsors.
- Cenduit (IQVIA): Cenduit, an IQVIA company, is a leading provider of IRT/RTSM and clinical supply management technology for clinical trials. It competes directly with Trialzen's forecasting and supply planning capabilities, particularly for sponsors looking to consolidate supply and IRT on a single platform.
Others
- Catalent: Catalent is a global CDMO offering clinical supply services and digital supply chain tools for pharma sponsors. Its Tony Street (now SVP Strategy at Trialzen) and Markus Vogt SVP backgrounds at Catalent/ThermoFisher highlight the talent crossover and the overlap in clinical supply planning conversations.
- Almac Group: Almac Group provides clinical trial supply services including packaging, distribution, and supply chain management with proprietary forecasting and optimization software. It is more of a services-led competitor but operates in the same clinical supply planning domain as Trialzen.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Trialzen social profiles
Digital presenceTrialzen compliance and trust
Trust signalCompliance2 records
Trialzen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trialzen leadership team
Management profileNumber of profiles
Profiles10 records
Trialzen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trialzen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trialzen
What does Trialzen do?
Trialzen develops and sells a SaaS platform, the Forecast & Planning Solution (FPS), that enables pharmaceutical sponsors to forecast, plan, and optimize the supply chain for clinical trials. The platform uses stochastic modeling and mathematical optimization to reduce clinical drug waste, optimize RTSM/IRT parameters, and run scenario simulations across complex protocol designs including adaptive trials and oncology studies. Customers access the platform via annual all-inclusive subscriptions and can also engage joint consultancy services through the Perceptive Clinical Intelligence alliance with Perceptive eClinical.
Is Trialzen a public or private company?
Trialzen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Trialzen founded?
Trialzen was founded in 2021. It employs 1 to 10 people.
Where is Trialzen based?
Trialzen is headquartered in Lasne-chapelle-saint-lambert, Belgium, in the Europe region.
How does Trialzen make money?
One revenue line is on record: saaS Subscription - Forecast & Planning Solution (FPS).
Who are Trialzen's main competitors?
Broad incumbents on record are Clario, Oracle Clinical One, Veeva Systems and Medidata (Dassault Systèmes). Direct peers are Signant Health, n-Side, 4G Clinical and Cenduit (IQVIA). Others are Catalent and Almac Group.
Does Trialzen have an API?
Yes. Trialzen FPS offers a standard API that enables business intelligence features and super-powerful reports that easily integrate with customer applications and dashboards. The API supports data exchange with RTSM/IRT systems and allows users to import RTSM data or use one-way integration to identify opportunities. Specific endpoints, authentication methods, rate limits, and versioning details are not publicly documented.
What industry is Trialzen in?
Trialzen's product category is Clinical Trial Supply Chain Software. Its primary akta.pro industry code is HLAGAOAH, Clinical Trial Supply, Logistics & Vendor Management FSP. Its NAICS code is 541512 and its SIC code is 7372.